Stock 300653 YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Yantai Zhenghai Biotechnology Co., Ltd.

Equities

300653

CNE100002NZ1

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
23.85 CNY +2.27% Intraday chart for Yantai Zhenghai Biotechnology Co., Ltd. +6.90% -17.82%
03/04 Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023. CI
01/04 Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.
CI
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Dividend for the Year 2023
CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Zhenghai Bio-Tech Gets Nod for Oral Restorative Film
MT
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.
CI
Yantai Zhenghai Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
CI
Yantai Zhenghai Biotechnology Co., Ltd. authorizes a Buyback Plan.
CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023
CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Cash Dividend for the 2022
CI
Zhenghai Bio-Tech Enrolls First Subject for Uterine Cavity Repair Membrane Trial
MT
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022
CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves Cash Dividend
CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300653 Stock
  4. News Yantai Zhenghai Biotechnology Co., Ltd.